Literature DB >> 20050881

Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.

Michele Pohlen, Bülent Sargin, Stefan Zicholl, Guido Bisping, Carsten Müller-Tidow, Wolfgang E Berdel, Rolf Mesters, Steffen Koschmieder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20050881     DOI： 10.1111/j.1600-0609.2009.01406.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  2 in total

Review 1.  Eltrombopag-based combination treatment for immune thrombocytopenia.

Authors:  David Gómez-Almaguer
Journal:  Ther Adv Hematol       Date:  2018-10-04

2.  Total remission of severe immune thrombocytopenia after short term treatment with romiplostim.

Authors:  Efthymia Vlachaki; Vaia Papageorgiou; Filippos Klonizakis; Maria Spandonidou; Sofia Chisan; Evaggelia Vetsiou; Elissavet Ioannidou
Journal:  Hematol Rep       Date:  2011-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.